dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp04558

General Description

Peptide name : MAP-04-03

Source/Organism : Analogs of Ixosin-B amide

Linear/Cyclic : Linear

Chirality : L

Sequence Information

Sequence : KWLRRVWRWWR

Peptide length: 11

C-terminal modification: Linear

N-terminal modification : Amidation

Non-natural peptide information: None

Activity Information

Assay type : MTT/MTS assay

Assay time : 48h

Activity : IC50 :61.5 µM

Cell line : MCF-7

Cancer type : Breast cancer

Other activity : Anti-microbial

Physicochemical Properties

Amino acid composition bar chart :

Molecular mass : 1728.0586 Dalton

Aliphatic index : 0.618

Instability index : 141.963

Hydrophobicity (GRAVY) : -1.590

Isoelectric point : 12

Charge (pH 7) : 4.7591

Aromaticity : 0.363

Molar extinction coefficient (cysteine, cystine): (22000, 22000)

Hydrophobic/hydrophilic ratio : 1.2

hydrophobic moment : -1.822

Missing amino acid : C,H,Q,T,P,M,I,E,F,S,D,Y,N,A,G

Most occurring amino acid : W

Most occurring amino acid frequency : 4

Least occurring amino acid : K

Least occurring amino acid frequency : 1

Structural Information

3D structure :

Secondary structure fraction (Helix, Turn, Sheet): (0.1, 0, 0.5)

SMILES Notation: CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C

Secondary Structure :

Method Prediction
GOR HHHHHHHHHHH
Chou-Fasman (CF) CCEEEEEECCC
Neural Network (NN) HHHHHHHHHHC
Joint/Consensus HHHHHHHHHHC

Molecular Descriptors and ADMET Properties

Molecular Descriptors: Click here to download

ADMET Properties: Click here to download

Cross Referencing databases

Pubmed Id : 23993331

Uniprot : Not available

PDB : Not available

CancerPPD : Click here

ApIAPDB : Not available

CancerPPD2 ID : Not available

Reference

1 : Hsiao YC, et al. Anticancer activities of an antimicrobial peptide derivative of Ixosin-B amide. Bioorg Med Chem Lett. 2013; 23:5744-7. doi: 10.1016/j.bmcl.2013.07.063

Literature

Paper title : Anticancer activities of an antimicrobial peptide derivative of Ixosin-B amide.

Doi : https://doi.org/10.1016/j.bmcl.2013.07.063

Abstract : In nature, antimicrobial peptides (AMPs) represent the first line of defense against infection by pathogens; thus, they are generally good candidates for the development of antimicrobial agents. Recently, we reported two potent antimicrobial peptides, KWLRRVWRWWR-amide (MAP-04-03) and KRLRRVWRRWR-amide (MAP-04-04), which were derived from a fragment of Ixosin-B-amide (KSDVRRWRSRY). Since some cationic AMPs exhibited cytotoxic activity against cancer cells, in the current study, we further investigated the anticancer activity of these potent antimicrobial peptides by antiproliferative assays and wound-healing assays, and the effect of peptide on the cytoskeleton alteration and cell morphology were analyzed by confocal microscopy. Results indicated that MAP-04-03 not only exhibited inhibitory effects on the proliferation (IC50=61.5 μM) and on the cell migration of MCF-7 breast cancer cells (at a concentration of 5 μM), but also affected the cytoskeleton at the concentration of 25 μM. These results demonstrated that MAP-04-03 can serve as a lead peptide analog for developing potent anticancer agents.